2021

1. Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

   Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420